Previous 10 | Next 10 |
Inogen has had a difficult YTD in its direct-to-consumer and business-to-business segments, directly from Covid-related headwinds. Steep declines in sales related to travel restrictions and purchase order cancellations have translated to pressures at the operating margin level. Ex...
Inogen, Inc. (NASDAQ: INGN ), a medical technology company offering innovative respiratory products for use in the homecare setting, today announced that the Company’s management will be participating in the Stifel 2020 Virtual Healthcare Conference. Inogen’s P...
Image source: The Motley Fool. Inogen Inc (NASDAQ: INGN) Q3 2020 Earnings Call Nov 4, 2020 , 4:30 p.m. ET Operator Continue reading For further details see: Inogen Inc (INGN) Q3 2020 Earnings Call Transcript
Inogen, Inc. (INGN) Q3 2020 Earnings Conference Call November 04, 2020, 04:30 PM ET Company Participants Matthew Pigeon - IR Scott Wilkinson - President and CEO Alison Bauerlein - CFO Conference Call Participants Danielle Antalffy - SVB Leerink Matthew Mishan - KeyBanc Mike Matson - Needham &...
Inogen Inc (INGN) Q3 2020 Results Conference Call October 4, 2020 4:20 PM ET Company Participants Matthew Basco - Investor Relations Scott Wilkinson - President and Chief Executive Officer Alison Bauerlein - Chief Financial Officer Conference Call Participants Danielle Antalffy - SVB Leerink ...
Gainers: [[ALTM]] +54.6%. [[UPWK]] +24.6%. [[QCOM]] +13.2%. [[APHA]] +10.1%. [[MTW]] +9.5%.Losers: [[BLUE]] -13.9%. [[ELF]] -9.4%. [[INGN]] -8.9%. [[AXNX]] -8.7%. [[PING]] -8.7%. For further details see: ALTM, UPWK, AXNX and INGN among after-hours movers
Inogen (INGN): Q3 GAAP EPS of -$0.08 misses by $0.10.Revenue of $74.3M (-19.0% Y/Y) misses by $1.76M.The Company does expect that the COVID-19 pandemic will continue to have an adverse impact on its business in the 4Q 2020 and that revenue in the 4Q 2020 will be down compared to the 3Q of 202...
– Q3 2020 Total Revenue of $74.3 million – Inogen, Inc. (NASDAQ: INGN ), a medical technology company offering innovative respiratory products for use in the homecare setting, today reported financial results for the three-month period ended Septemb...
Inogen, Inc . (Nasdaq: INGN ), a medical technology company offering innovative respiratory products for use in the homecare setting, announced that it will release third quarter 2020 financial results after market close on Wednesday, November 4 th , 2020. The Company will h...
Part of stock picking is having to deal with the occasional portfolio loser. These can be spotted if one’s long-term thesis has not played out the way you were expecting in terms of actual fundamental results. I’ve written about Inogen ( INGN ) in the past and my original thesis ...
News, Short Squeeze, Breakout and More Instantly...
Inogen, Inc. (Nasdaq: INGN ), a medical technology company offering innovative respiratory products for use in the homecare setting, today announced that it will report second quarter 2024 financial results after the market closes on Tuesday, August 6, 2024. On the same day, the Company wil...
Inogen, Inc. (Nasdaq: INGN ), a medical technology company offering innovative respiratory products for use in the homecare setting, today announced the appointment of Kevin P. Smith as General Counsel and Executive Vice President, Business Development, effective July 22, 2024. Mr. Smith jo...